Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mechanisms modulating estrogen-induced uterine vasodilation.

Charles R Rosenfeld1, Timothy Roy, Blair E Cox

  • 1Department of Pediatrics, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390-9063, USA. charles.rosenfeld@utsouthwestern.edu

Vascular Pharmacology
|October 17, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changes in mortality in very preterm neonates in a single institution in Dallas, Texas, 1977-2024: a cohort study.

Pediatric research·2026
Same author

Relationship between serum lipids/adipokines and obesity/hypertension in very-preterm infants during early childhood and preadolescence.

Pediatric research·2025
Same author

Post-extubation using high nCPAP: are we ready for the change?

Translational pediatrics·2024
Same author

A validated NICU database: recounting 50 years of clinical growth, quality improvement and research.

Pediatric research·2024
Same author

Follow-up of a randomized trial optimizing neonatal nutrition in preterm very low birthweight infants: growth, serum adipokines, renal function and blood pressure.

Journal of perinatology : official journal of the California Perinatal Association·2023
Same author

Relationship between Ventricular Size on Latest Ultrasonogram and the Bayley Scores ≥ 18 Months in Extremely Low Gestational Age Neonates: A Retrospective Cohort Study.

American journal of perinatology·2023

Estrogen significantly increases uterine blood flow, mediated by nitric oxide, smooth muscle cGMP, potassium channels, and new protein synthesis. Voltage-gated potassium channels and protein synthesis are key to estrogen

Area of Science:

  • Reproductive Physiology
  • Vascular Pharmacology

Background:

  • Estrogen is a potent vasodilator, significantly increasing uterine blood flow (UBF).
  • High-conductance potassium channels and nitric oxide (NO) are known contributors to estrogen's uterine effects.
  • Other factors modulating estrogen-induced vasodilation remain to be fully elucidated.

Purpose of the Study:

  • To investigate the role of ATP-dependent (KATP) and voltage-gated (Kv) potassium channels in estrogen-mediated uterine vasodilation.
  • To examine the involvement of new protein synthesis in estrogen's effects on uterine blood flow.
  • To elucidate the signaling pathways underlying estrogen-induced uterine vasodilation in vivo.

Main Methods:

  • Ovariectomized ewes with uterine artery flow probes were used.

Related Experiment Videos

  • Intraarterial inhibitors glibenclamide (KATP), 4-aminopyridine (Kv), and cycloheximide were infused into one uterine horn.
  • Systemic estradiol-17 beta (E2 beta) was administered, and UBF, heart rate, and mean arterial pressure (MAP) were monitored.

    • Main Results:

    • Estradiol-17 beta (E2 beta) increased UBF >5-fold and heart rate, without affecting MAP.
    • 4-aminopyridine (4-AP) dose-dependently inhibited E2 beta-induced UBF increases in the infused horn.
    • Cycloheximide dose-dependently inhibited UBF responses and uterine cGMP secretion, significantly reducing both.
    • Glibenclamide (GLB) did not affect basal hemodynamics or E2 beta responses.

    Conclusions:

    • Estrogen-induced uterine vasodilation involves voltage-gated potassium channels and new protein synthesis.
    • Nitric oxide (NO) and smooth muscle cyclic guanosine monophosphate (cGMP) signaling pathways are integral to these mechanisms.
    • These findings highlight the complex signaling cascade mediating estrogen's potent vasodilatory effects in the uterine vasculature.